An Overview of Edurant (Rilpivirine)June 1, 2011 Brand Name: Edurant Rilpivirine, also known as Edurant, is a type of medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). Rilpivirine works by disrupting one of the early steps in the HIV life cycle, called reverse transcription. During normal reverse transcription, HIV's reverse transcriptase enzyme (a type of protein) converts HIV's RNA -- a single strand of genetic information -- into DNA -- a double strand of genetic information. It does this by recoding the RNA building blocks into complementary DNA building blocks. As the HIV life cycle proceeds, the newly formed DNA is used to make more copies of HIV virus. When rilpivirine is present, however, it attaches directly to reverse transcriptase, blocking the conversion of RNA into DNA. This process prevents virus replication and halts the HIV life cycle. Indications and UsageRilpivirine was approved by the U.S. Food and Drug Administration (FDA) on May 20, 2011, for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults who have not taken HIV medicines before (treatment-naive adult patients). Rilpivirine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people. Dosage Form/AdministrationAlways take this medication as your doctor instructs. Rilpivirine tablets are taken by mouth with food (a meal), and rilpivirine is always used in combination with other anti-HIV medications. Dosage forms and strengths
What storage conditions are needed for this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication. In case of emergency/overdose In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911. What other information should I know?
Recommended Daily Dose
What should I do if I forget a dose? Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed dose. ContraindicationsWhat special precautions should I follow? Before taking rilpivirine,
Possible Side EffectsRilpivirine may cause side effects. The following life-threatening or serious side effects have been reported. Contact your doctor immediately if you experience:
Common side effects that may be associated with rilpivirine include the following. Let your doctor know if any of these side effects do not go away or worsen:
Rilpivirine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication. If you experience a serious side effect, you or your doctor may send a report to the U.S. FDA's MedWatch Adverse Event Reporting program online at www.fda.gov/Safety/MedWatch or by phone at 1-800-332-1088. Drug InteractionsRilpivirine may interact with other medicines. Before taking rilpivirine, it is important to tell your doctor about any prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. You should not take rilpivirine with the following medicines:
Other medicines that may interact with rilpivirine and should be used with caution include the following:
In addition to the lists above, there are other medicines that may interact with rilpivirine. For a complete list of all medicines that may interact with rilpivirine, talk with your doctor or pharmacist and check the manufacturer's Web site for the full prescribing information. What special dietary instructions should I follow? Unless your doctor tells you otherwise, continue your normal diet. Rilpivirine should always be taken with food (a meal). Clinical TrialsClick here to search ClinicalTrials.gov for trials that use Rilpivirine. Manufacturer InformationEdurant Rilpivirine This article was provided by AIDSinfo. Visit the AIDSinfo website to find out more about their activities and publications.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|